Acrivon Therapeutics, Inc.

Develops precision cancer therapies by matching patients to drugs using its proteomics platform.

ACRV | NDAQ

Overview

Corporate Details

ISIN(s):: US0048901096
LEI:
Country:: United States of America
Address:: 480 ARSENAL WAY, SUITE 100, 2472 WATERTOWN
Website:: https://acrivon.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Acrivon Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in precision oncology. The company leverages its proprietary Acrivon Predictive Precision Proteomics (AP3) platform to develop targeted cancer therapies. The AP3 platform utilizes phosphoproteomics to analyze the biologic drivers of a patient's cancer, enabling the creation of predictive 'OncoSignature' tests. This method is designed to match drug candidates with patients whose tumors are most likely to respond, aiming to improve therapeutic outcomes beyond what is achievable with genomics. Acrivon's pipeline is led by ACR-368, a selective kinase inhibitor in Phase 2 clinical trials for various solid tumors. The company also advances its internally developed programs and seeks strategic partnerships to apply its AP3 platform to co-develop predictive tests for external drug candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Acrivon Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Acrivon Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Acrivon Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
DBV Technologies Developing non-invasive skin patch immunotherapy for severe food allergies like peanut and milk.	France	DBV
DD GROUP Co.,Ltd. Operates a diverse portfolio of food service, amusement, and hotel brands.	Japan	3073
Decollte Holdings Corporation A nationwide network of studios offering modern wedding photography and wellness services.	Japan	7372
Dedem SpA Diversified group providing photo booths, amusement rides, 3D printing, and tech solutions.	Italy	DDM
Dedicare European recruitment and staffing firm for healthcare, life science, and social work sectors.	Sweden	DEDI
Delta-Fly Pharma, Inc. Develops innovative, gentle anticancer agents with reduced side effects for cancer patients.	Japan	4598
DENISON MINES CORP. Uranium exploration and development company advancing projects in Canada's Athabasca Basin.	United States of America	DNN
DENTSU GROUP INC. Global advertising & marketing firm integrating tech and consulting for brand growth.	Japan	4324
DGA S.A. Consulting, training, and EU-funded project services for public and private organizations.	Poland	DGA
DIGITAL HOLDINGS,INC. Drives business DX with data-driven advertising, CRM consulting, and AI integration.	Japan	2389